Tag: Caretalk

COVID-19 vaccine. Should we prioritize efficiency or equity?

March 5th, 2021 by

In this episode of CareTalk, CareCentrix CEO John Driscoll and I tussle about whether to emphasize equity or efficiency in the rollout of the COVID-19 vaccine. John’s in the equity camp while I lean more toward efficiency and broader societal impact and challenge whether there is actually a tradeoff.

Can pro sports beat the pandemic?

August 3rd, 2020 by

 

The sudden shutdown of pro sports in March was a shock to the system that made COVID-19 real to the public at large. Wouldn’t it be nice if the restart signaled the end of the pandemic? Alas, it’s instead become a reminder of just how serious a mess we are in.

In this episode of #CareTalk, John Driscoll and I discuss

(0:12) Can any professional sport safely continue operations during the pandemic?
(1:16) The MLB’s “Fish problem”
(3:20) Can Canada do it better? (6:00)
What about the NFL? (8:43)
Where is the USA in the battle against COVID-19?

When will COVID-19 vaccine become available?

July 24th, 2020 by

Operation Warp Speed promises a vaccine in no time (or at least before the election). Is that a pipe dream? And when the vaccine does arrive, how well will it work? How will it be priced? Who will get it? And what will the impact be on the rest of the drug and vaccine market?

John Driscoll and I argue it out in the latest edition of #CareTalk.


—-

 

By healthcare business consultant David E. Williams, president of Health Business Group.

Should meat plants reopen? #CareTalk tackles this meaty topic

May 4th, 2020 by

In the latest episode of #CareTalk, CareCentrix CEO John Driscoll and I talk about whether it’s right to make meat plants reopen. We also ponder  whether public health after #COVID19 will look like security after 9/11. As if that wasn’t enough for one episode, we tacked on a debate on why emergency room use has plummeted and whether telehealth is here to stay.

If you like what you see, remember to subscribe.

#CareTalk February 2019: Medicare for All?

February 28th, 2019 by

The latest edition of #CareTalk is out. CareCentrix CEO, John Driscoll and I explore Medicare for All and other big topics.

Here’s what we covered:

(0:35) Is “Medicare for All” quickly becoming a litmus test for Democratic presidential candidates?

(2:45) What should be made of the recent moves of home health agencies around primary care?

(5:00) Are pharma rebates to blame for increased drug pricing?

(8:00) President Trump promised a whopping $50 million a year for childhood cancer. What would you do with all that money?

(8:32) Will adding the full list price of drugs in ads make a difference?

(9:03) Will Donald Trump actually end HIV transmission by 2030?

(9:32) We predicted that the Patriots would win the championship this year. What about the other Boston sports teams?

Subscribe to the #CareTalk Podcast
iTunes: https://apple.co/2DIDTcr
Google Play: https://bit.ly/2RobqMB